Prevention of cervical cancer in HIV seropositive women from developing countries:a systematic review protocol
| Autor: | Tsungai Chipato, Witness Mapanga, Shingairai A. Feresu, Ahmed Elhakeem, Fresier Maseko |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
cervical cancer Population MEDLINE lcsh:Medicine Uterine Cervical Neoplasms Medicine (miscellaneous) Cochrane Library 03 medical and health sciences 0302 clinical medicine HIV Seropositivity Protocol medicine Humans 030212 general & internal medicine education Developing Countries Gynecology Cervical cancer education.field_of_study Cancer prevention business.industry Prevention lcsh:R Cancer HIV Retrospective cohort study developing countries medicine.disease Systematic review Research Design 030220 oncology & carcinogenesis Family medicine Female business Systematic Reviews as Topic |
| Zdroj: | Mapanga, W, Elhakeem, A, Feresu, S, Maseko, F & Chipato, T 2017, ' Prevention of cervical cancer in HIV seropositive women from developing countries : a systematic review protocol ', Systematic Reviews, vol. 6, 91 . https://doi.org/10.1186/s13643-017-0484-9 Systematic Reviews Systematic Reviews, Vol 6, Iss 1, Pp 1-7 (2017) |
| Popis: | Background Over 85% of cervical cancer cases and deaths occur in developing countries. HIV-seropositive women are more likely to develop precancerous lesions that lead to cervical cancer than HIV-negative women. However, the literature on cervical cancer prevention in seropositive women in developing countries has not been reviewed. The aim of this study is to systematically review cervical cancer prevention modalities available for HIV-seropositive women in developing countries. Methods/design This protocol was developed by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement, and the systematic review will be reported in accordance with the PRISMA guidelines. Embase, MEDLINE, PubMed, CINAHL and Cochrane Library will be searched from inception up to date of final search, and additional studies will be located through citation and reference list tracking. Eligible studies will be randomised controlled trials, prospective and retrospective cohort studies, case-control and cross-sectional studies carried out in developing countries. Studies will be included if they are published in English and examine cervical cancer prevention modalities in HIV-seropositive women. Results will be summarised in tables and, where appropriate, combined using meta-analysis. Discussion This review will address the gap in evidence by systematically reviewing the published literature on the different prevention modalities being used to prevent cervical cancer in HIV-seropositive women in developing countries. The findings may be used to inform evidence-based guidelines for prevention of cervical cancer in seropositive women as well as future research. Systematic review registration PROSPERO CRD42017054678. Electronic supplementary material The online version of this article (doi:10.1186/s13643-017-0484-9) contains supplementary material, which is available to authorized users. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|